Ca
-binding protein 2 (CaBP2) inhibits the inactivation of heterologously expressed voltage-gated Ca 2+ channels of type 1.3 (Ca V 1.3) and is defective in human autosomal-recessive deafness 93 (DFNB93). Here, we report a newly identified mutation in CABP2 that causes a moderate hearing impairment likely via nonsense-mediated decay of CABP2-mRNA. To study the mechanism of hearing impairment resulting from CABP2 loss of function, we disrupted Cabp2 in mice (Cabp2
LacZ/LacZ
). CaBP2 was expressed by cochlear hair cells, preferentially in inner hair cells (IHCs), and was lacking from the postsynaptic spiral ganglion neurons (SGNs). Cabp2
LacZ/LacZ mice displayed intact cochlear amplification but impaired auditory brainstem responses. Patch-clamp recordings from Cabp2
LacZ/LacZ IHCs revealed enhanced Ca 2+ -channel inactivation. The voltage dependence of activation and the number of Ca 2+ channels appeared normal in Cabp2
LacZ/LacZ mice, as were ribbon synapse counts. Recordings from single SGNs showed reduced spontaneous and sound-evoked firing rates. We propose that CaBP2 inhibits Ca V 1.3 Ca
2+
-channel inactivation, and thus sustains the availability of Ca V 1.3 Ca 2+ channels for synaptic sound encoding. Therefore, we conclude that human deafness DFNB93 is an auditory synaptopathy. -channel complexes are known to contain Ca V 1.3 α1 subunit (Cav1.3α1) (3) (4) (5) , betasubunit 2 (Ca V β2) (6) , and alpha2-delta subunit 2 (α2δ2) (7) to activate at around −60 mV (8) (9) (10) , and are partially activated already at the IHC resting potential in vivo [thought to be between −55 and −45 mV (11, 12) ], thereby mediating "spontaneous" glutamate release during silence (13) .
Compared with Ca V 1.3 channels studied in heterologous expression systems, Ca V 1.3 channels in IHCs show little inactivation, which has been attributed to inhibition of calmodulin-mediated Ca 2+ -dependent inactivation (CDI) (14) (15) (16) (17) by Ca 2+ -binding proteins (CaBPs) (18, 19) and/or the interaction of the distal and proximal regulatory domains of the Ca V 1.3α1 C terminus (20) (21) (22) . This "noninactivating" phenotype of IHC Ca V 1.3 enables reliable excitation-secretion coupling during ongoing stimulation (23) (24) (25) . In fact, postsynaptic spike rate adaptation during ongoing sound stimulation is thought to reflect primarily presynaptic vesicle pool depletion, with minor contributions of Ca V 1.3 inactivation or AMPA-receptor desensitization (23) (24) (25) (26) . CaBPs are calmodulin-like proteins that use three functional out of four helix-loop-helix domains (EF-hand) for Ca 2+ binding (27) . They are thought to function primarily as signaling proteins (28) and differentially modulate calmodulin effectors (29, 30) . In addition, CaBPs might also contribute in buffering free cytosoloic Ca 2+ ions, as do other small EF-hand calcium-binding proteins, such as calretinin, calbindin-D-28k, and parvalbumin-α (31) (32) (33) . The relevance of the individual CaBPs expressed in IHCs [CaBP1, CaBP2, CaBP4, and CaBP5 (18, 19, 34) ] for inhibiting CDI and for hearing is not understood well. Genetic disruption of Cabp4 in mice caused a very modest increase in CDI of IHC Ca 2+ influx and left hearing intact (18) . Recently, a mutation in the CABP2 gene was shown to cause recessive sensorineural hearing impairment [DFNB93 (35) ]. Specifically, this splice site mutation in CABP2 is thought to cause a frameshift resulting in a premature truncation of a CaBP2 amino acid sequence lacking the C-terminal EF hands 3 and 4. The truncated CaBP2 less potently inhibited Ca V 1.3 inactivation when studied in HEK293-T cells. This observation suggested that enhanced inactivation of Ca V 1.3 channels might Significance Ca 2+ channels mediate excitation-secretion coupling and show little inactivation at sensory ribbon synapses, enabling reliable synaptic information transfer during sustained stimulation. Studies of Ca 2+ -channel complexes in HEK293 cells indicated that Ca 2+ -binding proteins (CaBPs) antagonize their calmodulindependent inactivation. Although human mutations affecting CABP2 were shown to cause hearing impairment, the role of CaBP2 in auditory function and the precise disease mechanism remained enigmatic. Here, we disrupted CaBP2 in mice and showed that CaBP2 is required for sound encoding at inner hair cell synapses, likely by suppressing Ca 2+ -channel inactivation. We propose that the number of activatable Ca 2+ channels at the active zone is reduced when CaBP2 is lacking, as is likely the case with the newly described human CABP2 mutation.
contribute to the hearing impairment DFNB93. Moreover, DFNB93 might arise from impaired excitation-secretion coupling due to a depolarized shift of Ca 2+ -channel activation as was postulated for CABP4 disruption in photoreceptors in congenital stationary night blindness (36) . Finally, CaBP2 reduced the Ca 2+ -current density in HEK293-T cells, which was not found with the truncated CaBP2 reported to cause DFNB93 (35) . Therefore, excess Ca 2+ influx and glutamate release might cause excitotoxic synapse loss [excitotoxicity during loud noise (37)] in DFNB93.
Here, we describe an unreported human CABP2 loss-of-function mutation and analyze auditory function of a newly generated Cabp2-deficient mouse line at the synaptic, cellular, and systems levels. Lack of Cabp2 enhanced inactivation of Ca 2+ influx in IHCs, whereas its amplitude and voltage dependence of activation were normal. Cabp2 deficiency caused reduced and more jittered action potential firing in SGNs and impaired auditory brainstem responses (ABRs) despite intact cochlear amplification. This observation indicates that a synaptic hearing impairment underlies DFNB93.
Results

A Newly Identified Loss-of-Function Mutation in CABP2 Causes
Recessive Hearing Loss. The family (pedigree is shown in Fig.  1A ) of the affected subjects [a 16-y-old male subject (III:1) and his 11-y-old sister (III:3)] originated from Northern Italy. For the clinical and genetic studies, both parents were also enrolled and all subjects underwent full clinical examinations, excluding syndromic features. Apart from presbyacusis in subjects I:1 and I:4, there was no history of hearing defects in the family. Pedigree reconstruction indicated a common ancestor of the subjects' parents (II:2 and II:5) in the first half of the 19th century. Both affected subjects presented prelingual hearing impairment affecting their communication. Tympanometry indicated normal middle ear function. Pure-tone air conduction audiometry revealed symmetrical moderate-to-severe hearing impairment across all frequencies, preferentially affecting the middle-frequency range ("U shape"; Fig. 1C ). This feature led to screening for mutations in the TECTA and CABP2 genes, which are known to cause an audiometric phenotype similar the one observed in the subjects (35, 38) .
PCR amplification of all seven CABP2 exons, followed by bidirectional Sanger capillary sequencing, allowed us to identify a homozygous G-to-T transversion at nucleotide 466 in exon 5 (c.466G > T) in the DNA of subject III:1 (Fig. 1B, Top) . The mutation creates a premature stop codon (TAG), likely resulting in a loss of function due to nonsense-mediated mRNA decay (schematic is shown in Fig. 1D ). The same CABP2 c.466G > T mutation was found in the homozygous state in the proband's sister (III:3), whereas both parents (II:2 and II:5), the younger unaffected child (III:4), and three other family members (I:1, I:4, and II:4) were carriers of a single copy of the mutated allele (Fig.  1B, Middle) . The presence of the c.466G > T variant was excluded from a sample of 225 control white subjects by restriction analysis of a PCR amplicon encompassing the mutant nucleotide (Fig. 1B, Bottom) . Moreover, there was no G > T sequence variant reported at position 466 in the database of the Exome Aggregation Consortium (exac.broadinstitute.org/). In the four children and their parents, the chromosomal region encompassing the CABP2 c.466G > T locus was also genotyped for four microsatellites (D11S1765, D11S913, D11S1889, and D11S1337) and four single-nucleotide polymorphisms (rs2256154, rs630172, rs1695, and rs1531514) by capillary electrophoresis of fluorescently labeled PCR amplicons and direct sequencing of PCR products, respectively. Mutation-bearing chromosomes shared a common haplotype (Fig. 1E) , thus confirming that the pathogenic variant is identical by descent in both parents and has been inherited from a common ancestor, as suggested by pedigree reconstruction.
In conclusion, we identified a mutation in CABP2 (c.466G > T) that causes a recessive nonsyndromic hearing impairment similar to what we previously described for a splice site mutation in CABP2, which is thought to truncate the CaBP2 amino acid sequence. We postulate that both alleles disrupt CaBP2 function and assume that the c.466G > T mutation compromises CaBP2 function via nonsense-mediated mRNA decay. The tone audiograms were comparable between both mutant CABP2 genotypes (35) . However, unlike in our previous report, a transitory evoked otoacoustic emission (TEOAE) was observed in subject III:1 in the course of clinical examination at the age of 4 y (subject III:3 was not tested for TEOAE). This finding suggests that, at least initially, the CABP2 mutation spared cochlear amplification by outer hair cells (OHCs) and might arise at the level of IHCs in their ribbon synapses or the SGNs. To elucidate the disease mechanism further and study the role of CaBP2 in hearing, we turned to analysis in mice.
Cabp2 Is Expressed in Inner Ear Hair Cells and Is Required for Normal
Hearing in Mice. We generated a DFNB93 mouse model by using mouse ES cells of the Knockout Mouse Project (KOMP) repository (CSD50029, DEPD0003_7_F06) that contain an IRES:LacZ trapping cassette in the locus of the Cabp2 gene, followed by loxPflanked exons 3 and 4 for Flp-and Cre-mediated conditional deletion ( Fig. 2A) . We derived constitutive Cabp2
LacZ/LacZ mutants with globally defective Cabp2 function by crossing mice carrying the floxed Cabp2 allele with a Cre-driver line that expresses Cre-recombinase under the promoter of the transcription factor EIIa (39) . Cabp2
LacZ/LacZ mice were born at Mendelian ratio and were viable and fertile.
First, we studied the expression of Cabp2 using RT-PCR of the cochlea and LacZ staining of various nervous tissues. Within the cochlea, mRNA for the long Cabp2 isoform was detected in wildtype mice and Cabp2 mRNA was absent in Cabp2
LacZ/LacZ mice (Fig. 2B) . The LacZ signal was restricted to hair cells, with a much stronger staining in IHCs than in OHCs (Fig. 2 C and C′) . In addition, we found LacZ signal in vestibular hair cells (Fig. 2C′′ ) and in some cells in the outer retina, potentially representing horizontal cells (Fig. 2C′′′ ) because they were positive for calbindin-D-28k (Fig. S1C) . Sagittal sections of the whole brain appeared to lack LacZ staining (data not shown). Efforts to immunolocalize Cabp2 in IHCs failed with commercially available and newly generated antibodies using various protocols, which resulted in either unspecific staining or lack of staining (data not shown).
Next, we performed recordings of ABRs (reflecting neuronal activity along the early auditory pathway) and of otoacoustic emissions for a first characterization of hearing in Cabp2
LacZ/LacZ mice. ABR amplitudes were reduced (Fig. 3A) and ABR thresholds were elevated in the frequency range of 6-24 kHz (Fig. 3B ) in 8-wk-old Cabp2
LacZ/LacZ mice of either sex. Heterozygous mice showed normal ABRs (Fig. S1D ) consistent with the autosomal recessive phenotype observed for human CABP2 mutations. The thresholds and amplitudes of distortion product otoacoustic emissions (DPOAEs) were comparable between Cabp2
LacZ/LacZ mutants and their littermate controls ( Fig. 3 C and D). We probed retinal processing by scotopic electroretinography (ERG), which appeared intact in Cabp2
LacZ/LacZ mice (ERGs were not tested at photopic conditions). In summary, within the ear, Cabp2 is expressed in IHCs, OHCs, and vestibular hair cells but not in cochlear spiral ganglion neurons. Based on this expression pattern and our recordings of ABRs and DPOAEs, we hypothesize that the impairment of auditory processing occurs downstream of hair cell mechanoelectrical transduction and OHC amplification, most likely at the IHC synapses, a condition also known as auditory synaptopathy (40) . 
Cabp2 Disruption Does Not Alter the Number and Gross Molecular
Anatomy of IHCs and Their Afferent Synapses. We studied the number and gross morphology of IHCs and their afferent synapses using confocal microscopy of immunolabeled organs of Corti. Using parvalbumin-α or Ctbp2/RIBEYE as a hair cell marker, we did not find an obvious IHC loss in Cabp2
LacZ/LacZ mice at the age of 2-3 and 8 wk (Fig. S2 ). The development of IHCs appeared unaffected, as tested by staining of small-and large-conductance Ca 2+ -activated K + channels (SK and BK, respectively) after the onset of hearing ( Fig. S2 A and B) . As expected for normal postnatal IHC maturation, BK channels were located at the neck region of IHCs and SK2 puncta were absent in IHCs (but present in OHCs) of Cabp2
LacZ/LacZ mice at postnatal day 15 (P15; Fig. S2B ). The number of ribbon-occupied synapses, identified as juxtaposed spots of CtBP2/RIBEYE (marking the presynaptic ribbon) and GluA2/3 (marking the postsynaptic glutamate receptor clusters) immunofluorescence (41) , as well as the total number of synapses (GluA2/3 spots), were indistinguishable between Cabp2
LacZ/LacZ mutants and littermate controls at 3 and 8 wk of age ( Fig. S2 C-E). This observation rules out the possibility that DFNB93 was caused by a loss of IHCs or their synapses (e.g., due to degeneration or glutamate excitotoxicity . This observation contrasts with our previous report of a reduction in current density when coexpressing CABP2 in HEK293-T cells (35) , which might reflect a selection bias related to cell viability issues due to the noninactivating Ca 2+ influx in the absence of a negative feedback. Moreover, we observed that CABP2 shifted the voltage dependence of Ca V 1.3 activation to more hyperpolarized potentials [ Fig. S3B ; potential of half-activation (V 0.5 ) of −35.4 ± 1.5 mV compared with Ca V 1.3 alone: −20.8 ± 1.1; P < 0.001, Student's t test] as previously reported for Ca V 1.4 (36) . This observation primarily reflected an increased voltage sensitivity, because the slope factor of the activation function (k act ) was significantly smaller when coexpressing CABP2 ( Fig. S3B ; P < 0.005, Student's t test). Under these recording conditions, we confirmed the potency of CABP2 to inhibit Ca V 1.3 Ca 2+ -current inactivation (35) (Fig. S3 C-E) .
Next LacZ/LacZ (n = 8) and Cabp2 +/+ (n = 9) mice at f1 = 9.4 kHz and f2 = 11.3 kHz are shown. DPOAEs were comparable between both genotypes at the age of 8 wk, indicating intact active cochlear amplification in Cabp2-deficient mice (P > 0.05, two-way ANOVA). Error bars represent SEM. n.s., P > 0.05.
(amplitude: 0.217 ± 0.027 for Cabp2 LacZ/LacZ vs. 0.114 ± 0.028 for Cabp2 +/+ ; P < 0.05, Student's t test) and the slower linear (slope: 0.607 ± 0.011 for Cabp2
LacZ/LacZ vs. 0.257 ± 0.040 for Cabp2
+/+ ; P < 0.01, Student's t test) components of Ca V 1.3 inactivation were increased, whereas the time constant of the fast component was unaltered (τ inactivation : 38.3 ± 6.9 ms for Cabp2
LacZ/LacZ vs. 39.3 ± 7 ms for Cabp2
To gain further insight into the type of inactivation, we also studied IHCs of 2-to 3-wk-old Cabp2
LacZ/LacZ mice at room temperature for easier manipulation of the preparation. We chose midcochlear IHCs because the ABR impairment was most evident in the range of 12-16 kHz at this age (Fig. S4 A and B) . Using long depolarizations (500 ms to −14 mV; Fig. S4C ) or trains of brief depolarizations (10 ms to −14 mV, 5-ms interval; Fig. S4F ), we observed a modest but significant increase in Ca V 1.3 inactivation in Cabp2
LacZ/LacZ IHCs (I 500,Ca :0.62 ± 0.03 for Cabp2
LacZ/LacZ vs. 0.73 ± 0.01 for Cabp2
+/+ ; P < 0.001, Student's t test). Interestingly, the enhanced Ca V 1.3 inactivation in mutant IHCs primarily represented more voltage-dependent inactivation (VDI), as demonstrated by residual Ba 2+ currents after 500 ms (I 500,Ba : 0.71 ± 0.02 for Cabp2
LacZ/LacZ vs. 0.78 ± 0.01 for Cabp2 +/+ ; P < 0.005, Student's t test; Fig. S4 D and E) . In addition, there was a trend toward increased CDI, calculated as the difference between residual Ba 2+ and Ca 2+ currents after 500 ms, which, however, did not reach statistical significance (P > 0.05, Wilcoxon rank sum test; Fig. S4E ). Although the data on Ca V 1.3 in Cabp2-deficient IHCs and in CABP2-expressing HEK293 cells jointly argue for inhibition of Ca V 1.3 inactivation by CaBP2 (Fig. 4 F- ... vs. Fig. S3 C-E) , they disagree about regulation of the voltage dependence of Ca 2+ -channel activation. We conclude that the heterologous expression system reconstitutes the regulation of Ca V 1.3 by CaBP2 in IHCs only partially.
Assessing Ca
2+
-induced exocytosis by perforated-patch membrane capacitance measurements did not reveal a reduction of exocytosis. In fact, we observed enhanced capacitance increments for long depolarizations (5-wk-old animals: P < 0.001 for 100 and 200 ms, Student's t test; Fig. S5 A and B) . This excess exocytosis was prevented after the coapplication of the synthetic Ca 2+ chelators ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) and 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA) in a ruptured-patch configuration (Fig. S5C) -buffer KO mice (42) . In summary, we found normal activation and deactivation but increased inactivation of Ca V 1.3 Ca 2+ currents in Cabp2-deficient IHCs.
Disruption of Cabp2 Impairs Synaptic Sound Encoding. One way to probe synaptic release largely independent from potential extrasynaptic exocytosis is to record the sound-evoked spiking of single SGNs, each of which is thought to be driven by a single active zone (42) . Therefore, and to analyze how Cabp2 deficiency affects synaptic sound encoding, we performed in vivo extracellular recordings from single SGNs where they enter the cochlear nucleus (43) . Spontaneous firing rates were reduced in Cabp2 LacZ/LacZ mice at the age of 5-8 wk ( Fig. 5A ; P < 0.001, pooling littermates and C57BL/6 controls). We then studied sound encoding by measuring SGN firing upon tone-burst stimulation. We found frequency tuning and spike rate thresholds (P = 0.21, for fibers with characteristic frequencies of 6-20 kHz) to be normal in SGNs of Cabp2
LacZ/LacZ mice ( Fig. S7 A and B) . This observation corroborates our notion of normal cochlear amplification (DPOAE; Fig. 3 C and D) . We recorded rate-level functions [firing rate vs. sound pressure level (SPL)] in response to tone bursts of different SPLs at the characteristic frequency (50 ms, applied at 5 Hz; Fig. S7C ). Neither the dynamic range of encoding nor the steepness of the rate-level functions was altered in Cabp2
LacZ/LacZ SGNs ( Fig. S7 D and E) . However, when studying maximal firing by tone bursts at saturating sound- ) of the first-spike latency (scattered against steady-state firing rate). Variance is increased in SGNs of Cabp2-deficient compared with Cabp2 +/+ animals (P < 0.05, Wilcoxon rank sum test).
pressure levels (50 ms, applied at 5 Hz, 30 dB above threshold at the characteristic frequency), we found reduced firing rates at sound onset and after short-term adaptation in Cabp2
LacZ/LacZ SGNs (Fig. 5B) . Congruent with the reduction in firing rates, firstspike latencies were delayed ( Fig. 5C ; 6.1 ± 0.3 ms vs. 4.9 ± 0.2 ms) and more variable ( Fig. 5D ; variance: 11.5 ± 3.6 ms 2 vs. 6.0 ± 1.5 ms
LacZ/LacZ SGNs. Rate reduction and increased jitter of SGN firing at sound onset likely explain the impaired ABR wave I amplitude and threshold.
The reduction in firing rates was also observed when using 500-ms tone bursts (applied at 0.5 Hz; Fig. S6F ). Here, adaptation was slightly more pronounced in Cabp2
LacZ/LacZ SGNs (36.4% vs. 20.5% reduction between 40-50 ms and 490-500 ms after stimulus onset). Interestingly, there was no increase of spike rate after short-term adaptation as would have been expected if the excess-sustained exocytosis observed in Cabp2-deficient IHCs reflected enhanced synaptic release. Therefore, such excess-sustained exocytosis likely occurs extrasynaptically and does not contribute to sound encoding, much like the suggested scenario for mice lacking the EF-hand calcium-binding proteins calbindin-D-28k, calretinin, and parvalbumin-α (42).
Discussion
Here, we studied the role of CaBP2 in hearing and characterized the disease mechanism of human sensorineural hearing impairment DFNB93. We identified a DFNB93 mutation that likely causes a complete loss of CABP2 function. Using constitutive genetic disruption of Cabp2, we generated a DFNB93 mouse model that showed a synaptic hearing impairment without loss of IHCs or their synapses with SGNs. We did not observe obvious deficits outside the auditory system, which is in keeping with the rather hair cell-specific expression of CaBP2 and the clinical findings in DFNB93 (this study and refs. 35, 44) . Elevated thresholds, reduced amplitudes and prolonged latencies of ABRs, of which the first peak reports the synchronous activation of SGNs, are likely accounted by the reduced firing rates and delayed, as well as more variable, spike timing of SGNs at sound onset. We propose that reduced firing of SGNs in Cabp2 channels stand out by reason of their hyperpolarized activation range and modest inactivation (10, 18, 19, 22, 45) . These properties have been attributed to the molecular composition of the native Ca 2+ -channel complexes that, in addition to the specific pore-forming Ca V 1.3α1 splice variant (46) , auxiliary Ca V β2 (6, 47) , and Ca V α 2 δ2 (7) subunit, also contain interactions partners, such as Rab3-interacting molecule (RIM) (48, 49) ; harmonin (50, 51); calmodulin; and, notably, CaBPs (this study and refs. 18, 19, 34) . CaBPs have been shown to confer both the negative activation (36) and the noninactivating (18, 19, 35, 52) phenotypes to Ca V channels in HEK293 cells. Our HEK293 cell study demonstrates that CaBP2 can potently shift Ca V 1.3 activation to more hyperpolarized potentials and inhibit Ca V 1.3 channel inactivation. Aiming to match the molecular composition of the IHC Ca V 1.3 channel complex closely and using coexpression of SK3-1 channels for avoiding potentially toxic Ca 2+ influx, we did not observe the previously reported decrease of Ca 2+ -current density upon CABP2 coexpression (35 -current inactivation (iii), on the other hand, was nearly doubled when probing Cabp2-deficient IHCs of 5-wk-old mice at near-physiological conditions (Fig. 4) , supporting the hypothesis that CaBP2 inhibits the inactivation of Ca V 1.3 Ca 2+ channels in IHCs in vivo. We note that Ca 2+ -current inactivation was previously shown to be temperature-dependent in IHCs of rats (16), likely explaining why we observed a smaller increase of inactivation at room temperature (Fig. S4) . There, we found significantly increased VDI and a nonsignificant trend toward increased CDI in IHCs of 2-to 3-wk-old Cabp2 LacZ/LacZ mice. A dual role in Ca 2+ -channel regulation was hypothesized for CaBP1: The N-lobe/linker regions were suggested to introduce Ca
2+
-dependent facilitation of Ca V 1.2 channels, whereas the C-terminal domains were required for the binding of CaBP1 to the IQ domain and inhibition of Ca V 1.2 CDI (55, 56). CaBP1 and CaBP2 share the N-terminal myristoylation as a common modification (27) and, unlike CaBP4 and CaBP5, were implicated in inhibiting VDI of Ca V 1.3 channels (18), suggesting that CaBP2 might regulate VDI via the N-lobe region. During VDI, the alpha interaction domain (AID) of Ca V 1.3α1 was shown to play a critical role (57), whereby the "lid" (Ca V β-AID complex) is thought to mediate VDI by binding segment 6 of Ca V 1.3α1, occluding the channel pore (58) . Hence, CaBP2 might attenuate VDI by shielding the Ca 2+ -channel pore from the Ca V β-AID complex. Aside from inhibition by CaBP2, Ca V 1.3 inactivation is also controlled by the C-terminal regulating domain present or absent depending on the precise Ca V 1.3 splice variant (20, 46) ; by the Ca V β subunit (6); and by interacting proteins, such as other CaBPs (18, 19) and RIM (48) .
Considering a biological system as complex as the auditory pathway with limited potential for molecular manipulation, it seems well-justified to characterize function and regulation of IHC-like Ca V 1.3 channels in a "simple" heterologous expression system, such as HEK293 cells. However, the differences found here clearly indicate the limitations of a heterologous expression system to represent the physiology of the native IHC Ca 2+ channels, likely because it has not fully recapitulated the molecular machinery constituting the presynaptic Ca V 1.3 Ca
-channel complex at the IHC active zone. Future studies in mice combining CaBP2 disruption with disruption of CaBP 1, CaBP4, and CaPB5, which are also expressed in IHCs (18, 19, 34) , will be important to comprehend the complex regulation of inactivation of IHC Ca 2+ channels.
Analysis of Cabp2-Deficient Mice Indicates That DFNB93 Is an Auditory Synaptopathy. The constitutive disruption of Cabp2 in mice likely provides an appropriate model for at least some cases of DFNB93, such as for the newly identified CABP2 mutation, which probably causes nonsense-mediated decay of Cabp2-mRNA. Hearing loss characterized by impaired ABR despite intact cochlear amplification as found in Cabp2 LacZ/LacZ mice is termed "auditory neuropathy" or "auditory synaptopathy," depending on the site of lesion (40, 59) . In keeping with this hypothesis, we observed otoacoustic emissions in one of the DFNB93 subjects described in the present study. As reported for otoferlinrelated synaptopathy, emissions might be lost secondarily (60), potentially explaining the absence in our previous study (35) 
LacZ/LacZ mice resulted from a dysfunction of the presynaptic active zone. Congruent with previous reports on DFNB93 (35, 44) , low to middle frequencies were most affected in human patients, suggesting that inhibition of Ca 2+ -current inactivation is predominantly required for normal perception of low-to middlefrequency sounds. In fact, in low-frequency hearing animals like bullfrogs, Ca 2+ -current inactivation was absent during sine-wave stimulation, supporting temporally precise glutamate release and phase-locked excitatory postsynaptic currents (61) . Future genetic manipulation in low-frequency hearing gerbils will be beneficial for our understanding of how Ca 2+ -current inactivation relates to the temporal precision of sound encoding.
In vivo postsynaptic recordings from SGNs revealed reduced rates of spontaneous and evoked synaptic transmission. Our analysis of Cabp2-deficient mouse IHCs indicated that the voltage dependence of IHC Ca 2+ influx was unaltered, ruling out a mismatch of the operating range of Ca V 1.3 channels and IHC receptor potentials, respectively, as a disease mechanism for DFNB93. These observations leave enhanced Ca V 1.3 inactivation as a plausible candidate mechanism for the reduced rates of transmission at the IHC synapses of Cabp2
LacZ/LacZ mice and for the human hearing impairment DFNB93. The reduction in spontaneous SGN firing observed in Cabp2
LacZ/LacZ mice suggests that some of the Ca V 1.3 channels are inactivated at the resting potential upon Cabp2 deficiency, because spontaneous firing depends on the opening of Ca 2+ channels (13) . Interestingly, unlike what is expected from findings in the normal cochlea, where SGNs with low spontaneous rates tend to display higher thresholds (43), we found SGNs that combined low spontaneous rates with low thresholds in Cabp2
LacZ/LacZ mice and thresholds were generally comparable to wild-type SGNs. We argue that impaired sound coding, also encompassing reduced temporal precision, characterizes the hearing impairment of human DFNB93 subjects.
We postulate that inactivation within the relatively depolarized operating range of IHCs (11, 12) reduces the number of synaptic Ca V 1.3 channels available for stimulus-secretion coupling in the absence of CaBP2. Membrane capacitance (C m ) measurements turned out to be of limited help for understanding the effect of CaBP2 disruption on synaptic exocytosis. An enhanced spread of the synaptic Ca 2+ signal to extrasynaptic release sites might account for excess sustained vesicle fusion, which possibly masked a reduction of synaptic exocytosis underlying the reduced SGN spike rates. Based on the normal sound-evoked firing of SGNs of mice lacking the EF-hand Ca 2+ buffers calbindin-D-28k, calretinin, and parvalbumin-α, we assume that the proposed impaired Ca 2+ buffering in CaBP2-deficient IHCs does not contribute to the sound coding deficit in Cabp2
LacZ/LacZ mice. Imaging synaptic Ca 2+ signals in CaBP2-deficient IHCs, as well as studying mice with IHC-specific Cabp2 deletion and virus-mediated rescue of CaBP2 function in IHCs, will be required to validate the Ca V 1.3 inactivation hypothesis of DFNB93 pathophysiology further.
Materials and Methods
Generation of the Cabp2
LacZ/LacZ Mouse Line. ES cells carrying the KO allele were provided by the KOMP repository, and the methods used were previously described (62) . The sequence integrity and the presence of the distal loxP cassette, together with the correct insertion of the targeted allele, were confirmed by long-range PCR assay of ES cell clones and subsequent sequencing according to the manufacturer's protocol (Fig. S1 A and B) . Primers used can be found on the KOMP web page. The primer pair to check insertion of the 3′ target allele is fwd3′ allele and rev3′ allele (primer list is provided in Table S1 ). The mutant mice were crossbred with EIIa-cre transgenic mice, resulting in a global Cabp2 mutant mouse line carrying a LacZ reporter after exon 2 of Cabp2. Mice of either sex were used at P14-P21, P35-P42, and P49-P62 for patch-clamping and immunohistochemistry, and at 3-8 wk for systems physiology. All experiments were performed in compliance with the national animal care guidelines and were approved by the Board for Animal Welfare of the University Medical Center Goettingen and the Animal Welfare Office of the state of Lower Saxony.
RT-PCR. Six organs of Corti were dissected and mRNA-isolated using TRIzol reagent (Invitrogen) according to the manufacturer's protocol. For RT, the GeneAmp RNA PCR Kit (Invitrogen) was applied and purified cDNA of Cabp2 +/+ and Cabp2 LacZ/LacZ was amplified by the following primer combinations: PCR-1: forward (fwd) Exon1, reverse (rev) Exon5; PCR-2: fwdLacZ, revExon5; and PCR-3: fwdGAPDH, revGAPDH (primer list is provided in Table S1 ).
LacZ Staining. Cochleae and retinae were isolated and fixed for 10 min in 0.2% glutaraldehyde with 5 mM EGTA and 2 mM MgCl 2 in 100 mM PB. Tissue was washed three times for 15 min each time in detergent rinse solution containing 0.02% Igepal, 0.01% 7-deoxycholic acid sodium salt, and 2 mM MgCl 2 in 100 mM PBS (pH 7.3). For the staining reaction, samples were kept in X-Gal staining solution: 0.02% Igepal, 0.01% 7-deoxycholic acid, 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 2 mM MgCl 2 , and 1 mg/mL X-Gal in 100 mM PBS (pH 7.3) overnight at 37°C.
Transient Transfection of HEK 293/hSK3-1 Cells. HEK293/hSK3-1 cells were maintained in Dulbecco's modified Eagle medium/F12 Glutamax (GIBCO), containing 10% (vol/vol) FBS and 400 μg/mL G418 at 37°C in a humidified atmosphere with 5% (vol/vol) CO 2 saturation. The cells were transfected with Ca V 1.3α1 (AF370010, amount: 1×), β 2A (BC117468, amount: 0.5×), α 2 δ1 (NM053851, amount: 0.5×), and CABP2-pEGFP-N1 (AB593136, amount: 0.05x) in ratios according to their length using the transfection reagent ExGen500 (Biomol) according to the manufacturer's protocol. The cells were used for electrophysiological recordings 36-48 h after transfection.
Patch-Clamp
Recordings. An EPC-10 amplifier and PatchMaster software (HEKA) were used for whole-cell patch-clamp recordings utilizing low-pass filtering at 5 kHz, sampling at 50 kHz, and R series compensation of 70% (R series compensation for HEK293 cell experiments only). The external solution for HEK293 cell recordings contained the following: 150 mM choline Cl, 1 mM MgCl 2 , 10 mM Cs-Hepes, 10 mM CaCl 2 , and 100 nM apamin (pH 7.4 with methanesulfonic acid and osmolarity of 300-310 mOsm). The internal solution for HEK293 cell recordings contained the following: 140 mM N-methyl-D-glucamine, 5 mM EGTA, 10 mM NaCl, 1 mM MgCl 2 , 10 mM Hepes, and 2 mM MgATP (pH 7.4, 290 mOsm). Recordings from IHCs were performed in the perforated-and ruptured-patch configurations. For the perforated-patch configuration, the pipette solution contained the following: 137 mM Csgluconate, 10 mM tetraethylammonium chloride (TEA-Cl), 10 mM 4-AP, 10 mM Cs-Hepes, 1 mM MgCl 2 , and 300 μg/mL amphotericin B (pH 7.2, 283 mOsm). For the ruptured-patch configuration, the pipette solution contained the following: 134 mM Cs-gluconate, 10 mM TEA-Cl, 10 mM 4-AP, 10 mM Cs-Hepes, 1 mM MgCl 2 , 0.5 mM EGTA, 0.5 mM BAPTA, 0.3 mM NaGTP, and 2 mM MgATP (pH 7.2, 283 mOsm). The standard bath solution contained the following: 113 mM NaCl, 35 mM TEA-Cl, 2.8 mM KCl, 1 mM CsCl, 1 mM MgCl 2 , mM 10 NaOH-Hepes, 11.3 mM D-glucose, and CaCl 2 concentrations (pH 7.2, 300-310 mOsm). All patch-clamp experiments were performed at room temperature, except for the recordings in near-physiological conditions, which also used 1.3 mM [Ca 2+ ] e . Cells were stimulated by depolarizations of different durations to −14 mV at intervals of 30-90 s. We measured and analyzed C m as previously described (25) . Exocytic C m increments were analyzed as the difference between C m during 400 ms before and after depolarization, skipping the first 100 ms after the end of the depolarizing pulse. All currents were leak-corrected subtracting the average and scaled passive current response, which was estimated from the responses to 10 subsequent depolarizations to 10% of the test depolarization and was multiplied by 10 (P/10). Voltage was corrected for liquid junction potentials calculated by the Patchers-Power-Tool of Igor-Pro (14 mV for perforated-patch experiments and 12.2 mV for HEK293/hSK3 recordings).
Systems Physiology: ABRs, Otoacoustic Emissions, and Electroretinography. For recordings of ABRs and DPOAEs, mice were anesthetized with a combination of i.p.-administered ketamine (125 mg/kg) and xylazine (2.5 mg/kg). The core temperature was maintained constant at 37°C using a heat blanket (Hugo Sachs Elektronik-Harvard Apparatus). For stimulus generation, presentation, and data acquisition, we used the TDT II System run by BioSig software (Tucker Davis Technologies, MathWorks). Tone bursts (4/6/8/12/16/24/32 kHz, 10-ms plateau, 1-ms cos2 rise/fall) or clicks of 0.03 ms were presented at 40 Hz (tone bursts) or 20 Hz (clicks) in the free field ipsilaterally using a JBL 2402 speaker. The difference potential between vertex and mastoid subdermal needles was amplified 50,000-fold, filtered (400-4,000 Hz), and sampled at a rate of 50 kHz for 20 ms for a total of 1,300 times to obtain two mean ABR traces for each sound intensity. Hearing threshold was determined with 10-dB precision as the lowest stimulus intensity that evoked a reproducible response waveform in both traces by visual inspection by two independent observers.
For DPOAE, continuous primary tones (frequency f2 = 1.2 * f1, intensity l2 = l1-10 dB SPL) were delivered through a MF1 speaker system (Tucker Davis Technologies) and a custom-made probe containing an MKE-2 microphone (Sennheiser). The microphone signal was amplified (DMX 6Fire; Terratec), and the DPOAE amplitude at 2 * f2-f1 was analyzed by fast Fourier transformation using custom-written MATLAB software (MathWorks). SPLs are provided in SPL root mean square decibels (tonal stimuli) or SPL peak equivalent decibels (clicks). ERGs were recorded as in the study by tom Dieck et al. (63) .
Single Auditory Nerve Fiber Recordings. Single-unit recordings were performed as described previously (43, 64, 65) . In short, mice were anesthetized by i.p. injection of urethane (1.32 mg/kg), xylazine (5 mg/kg), and buprenorphine (0.1 mg/kg); tracheostomized; and placed in a stereotactic apparatus. After partial removal of the occipital bone and cerebellum, the internal auditory meatus was approached with a glass microelectrode passing through the posterior portion of the cochlear nucleus. Auditory nerve fibers were distinguished from cochlear nucleus neurons based on their stereotactic position (>1.2 mm from the surface of the cochlear nucleus, electrode aiming at the internal auditory canal) and response characteristics (poststimulus time histogram, regularity of firing, first-spike latency).
Immunohistochemistry. The apical coil of the organ of Corti was isolated from P21-P28 or P49-P61 mice and fixed with 4% (vol/vol) paraformaldehyde in PBS (15 min for synapse stains and 1 h for BK and SK2 staining). For Ca For immunostaining of retinal slices, retinae were fixed for 120 min in 4% (vol/vol) paraformaldehyde in PBS at room temperature, and were subsequently washed in PBS and transferred into sucrose gradient solutions of 10% (wt/vol; 10 min, room temperature), 20% (wt/vol; 2 h, room temperature), and 25% (wt/vol; overnight, 4°C). After embedding the retina in cryomatrix (20 min; Life Technology), the tissue was frozen in a cryostat (−25°C, 2800 Frigocut; Reichert-Jung), sliced (thickness of 60 μm), and stored at −80°C until staining. The immunostaining procedure was the same as for the organs of Corti, just with chicken anti-β-galactosidase (1:100; Abcam) and mouse anti-α-calbindin D-28k (1:400). For anti-β-galactosidase antibody, a goat anti-chicken secondary AlexaFluor-labeled antibody (1:200; MoBiTec) was applied.
Protein Purification and Isothermal Titration Calorimetry. His6-tagged CABP2-wt (wild type) and GST-tagged CABP2-ΔEF3/4 were transformed into Escherichia coli BL21 (DE3) cells (Merck) and grown at 37°C. The expression was induced with 0.5 M isopropyl 1-thio-β-D-galactopyranoside at A 600 = 0.6 nm, and the temperature was set to 16°C. After 15-20 h, the cells were harvested by centrifugation, resuspended in lysis buffer [20 mM Tris (pH 7.5), 300 mM NaCl, 10% (wt/wt) glycerol], and disrupted using a fluidizer (Mircofluidics). After centrifugation (45 min, 39086.1 × g), the obtained supernatant of the His6-tagged CABP2-wt protein was loaded onto a nickelnitrilotriacetic acid column (GE Healthcare). To elute the protein, an elution gradient with imidazole-containing buffer [20 mM Tris (pH 7.5), 300 mM NaCl, 10% (vol/vol) glycerol, 500 mM imidazole] was performed, followed by size exclusion chromatography (S200 16/60; GE Healthcare) [20 mM Tris (pH 7.5), 300 mM NaCl, 10% (vol/vol) glycerol]. The GST-tagged CABP2-ΔEF3/4 protein was purified using a GST column (GE Healthcare) [20 mM Tris (pH 7.5), 300 mM NaCl, 10% (vol/vol) glycerol, elution buffer with 20 mM reduced glutathione], followed by size exclusion chromatography (S200 16/60) [20 mM Tris (pH 7.5), 300 mM NaCl, 10% (wt/wt) glycerol]. Both proteins were incubated with Chelex (Biorad) to remove remaining Ca 2+ ions. During the purification steps, the temperature was kept at 4°C. Isothermal titration calorimetry was performed using a VP-ITC microcalorimeter (MicroCal/GE Healthcare). The reference cell was filled with buffer, and the protein was placed in the sample cell in the same buffer. Each experiment was performed at 8°C with a protein concentration of 110 μM. The 5 mM CaCl 2 solution was prepared in buffer that was also treated with Chelex. Forty injections of 5 μL were added to the wild-type protein, and 35 injections of 5 μL were added to the mutant. To obtain a baseline after one injection, a time interval of 210 s was set; the used stirring speed was 307 rpm. Additionally, a titration of CaCl 2 in buffer was subtracted from the data to correct for heat of dilution. Each experiment was repeated three times. For data analysis and determination of the K d , ΔH and ΔS values were measured using MicroCal Origin software running MicroCal/GE Healthcare ITC analysis routines.
Data Analysis. Voltage of half-maximal Ca 2+ current (V 0.5 ) and activation constant (k act ) were calculated by first transforming the current-voltage (I-V) traces into an activation function: I Ca = g max (V −V rev ), where V describes the holding potential, V rev the reversal potential, and g max the maximum conductance. The activation function was fitted by a Boltzmann function: 1/(1 + exp((V 0.5 −V)/k act )). Data were analyzed using Igor Pro Software (Wavemetrics), Origin (MicroCal), and ImageJ. Means were expressed ± SEM and compared using two-tailed Student's t tests for normally distributed data of equal variance or else by the Wilcoxon rank sum test (if not stated otherwise), with *P < 0.05, **P < 0.01, and ***P < 0.005, respectively.
